Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
An Update of Immunohistochemistry in Hepatocellular Carcinoma
Diagnostics
September 2025
Li B.
Open Access
Pathology and diagnostic approaches to well-differentiated hepatocellular lesions: a narrative review
Journal of Yeungnam Medical Science
2025
Choi J.H.
Open Access
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Cancer Gene Therapy
August 2024
Safri F.
Open Access
Ancillary tests for hepatobiliary neoplasms: what we know and what we need to know
Human Pathology
November 2023
Zhang S.L.
Open Access
Large-scale tissue microarray evaluation corroborates high specificity of high-level arginase-1 immunostaining for hepatocellular carcinoma
Diagnostics
December 2021
Lennartz M.
Open Access
Pathological diagnosis of cholangiocarcinoma
Diagnosis and Management of Cholangiocarcinoma A Multidisciplinary Approach
28 May 2021
Sigel C.
Arginase-1 and P-glycoprotein are downregulated in canine hepatocellular carcinoma
Journal of Veterinary Science
2021
Kim S.H.
Open Access
Consensus for clinical application of molecular diagnosis on hepatobiliary carcinoma
Journal of Clinical Hepatology
July 2020
Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer
Clinical Biochemistry
May 2020
Liu S.
Diagnostic value of serum biomarkers in combined hepatocelluar-cholangiocarcinoma
Journal of the College of Physicians and Surgeons Pakistan
1 March 2020
Chen J.
Open Access
The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver
Journal of Gastrointestinal Cancer
1 March 2020
Labib O.H.
Consensus for clinical application of molecular diagnosis on hepatobiliary carcinoma
Chinese Journal of Hepatobiliary Surgery
28 February 2020
The significance of arginase-1 expression in the diagnosis of liver cancer: A protocol for a systematic review
Medicine United States
2020
Wang X.
Open Access
Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma
Translational Cancer Research
1 January 2020
Wang C.
Open Access
Update on Ancillary Testing in the Evaluation of High-Grade Liver Tumors
Surgical Pathology Clinics
June 2018
Koehne de Gonzalez A.
Diagnostic value of Glypican-3 for hepatocellular carcinomas
Asian Pacific Journal of Cancer Prevention
1 March 2018
El-Saadany S.
A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative
Human Pathology
November 2017
Clark I.
Expression of markers of hepatocellular differentiation in pancreatic acinar cell neoplasms: A potential diagnostic pitfall
American Journal of Clinical Pathology
1 August 2016
Askan G.
Open Access
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
Cancer Immunology Immunotherapy
1 March 2016
Spear T.T.
All Open Access, Green
Utility of an immunostaining panel for diagnosis of hepatocellular carcinoma in fine needle-aspiration biopsies of the liver
International Journal of Clinical and Experimental Pathology
2016
Xu J.
Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma
Bioscience Trends
2016
Yao M.
Open Access